PATENT CLAIM ANALYSIS

Application Number: 15896436
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "450000"]

Abstract:
The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provide methods of making the liposome compositions provided by the present invention.

Claim (Index 1):
A pharmaceutical composition comprising irinotecan sucrose octasulfate precipitated in a matrix comprising one or more phospholipids, wherein the matrix has a size of approximately 110 nm and comprises a total of 500-550 mg irinotecan base per mmol of total phospholipids.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 88.0
- Lexical Diversity: 1.3
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14879302', '14965140', '15296536', '14632422', '11121294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8585412232105022
- 35 USC 102 Novelty (BERT): 0.6970533221914561
- Combined Prediction Score: 0.8423924331085977
- Mean Citation Score: 810.5346599999997
- Max Citation Score: 833.715
- Similarity Product: 701.4639212688803

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test